| Financial Year |
March 31 2023 |
| Monetary Funds |
211,097,858.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
87,551,089.66 |
| Advances to Suppliers |
5,802,953.51 |
| Other Receivables |
8,649,290.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
28,998,636.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
106,413,220.06 |
| Other Current Assets |
4,792,643.86 |
| Total Current Assets |
453,305,692.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
243,964,999.61 |
| Long-term Equity Investment |
20,970,425.93 |
| Investment Properties |
-- |
| Fixed Assetes |
41,672,772.71 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,437,453.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,978.90 |
| Deferred Income Tax Assets |
59,159,743.30 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
397,047,279.49 |
| Total Assets |
850,352,971.70 |
| Short-Term Loans |
131,732,116.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
124,139,880.13 |
| Accounts Received In Advance |
169,536.22 |
| Employee Compensation Payable |
2,803,328.92 |
| Taxes Payable |
3,950,150.63 |
| Interest Payable |
41,919,097.64 |
| Dividend Payable |
240,900.00 |
| Other payables |
149,816,375.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,914,502.70 |
| Other Current Liabilities |
13,821,571.96 |
| Sub-Total of Current Liabilities |
439,062,950.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
24,796,558.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,902,647.68 |
| Total Liabilities |
484,965,597.69 |
| Paid-In Capital(Or Share Stock) |
2,178,303,106.00 |
| Capital Surplus |
1,419,737,962.01 |
| Surplus Reserve |
19,062,040.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,251,715,739.26 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
365,387,374.01 |
| Owner's Equity（Stockholder's Equity） |
365,387,374.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
850,352,971.70 |
